α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 101–200 of 826
Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders
Plotegher, N., & Duchen, M. R. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.003 · Cited by 161
ER–mitochondria signaling in Parkinson’s disease
Gómez-Suaga, P., Bravo-San Pedro, J. M., González-Polo, R. A., Fuentes, J. M., & Niso-Santano, M. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0079-3 · Cited by 164
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164
Autophagy, polyphenols and healthy ageing
Pallauf, K., & Rimbach, G. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.03.008 · Cited by 164
Ramonet, D., Podhajska, A., Stafa, K., Sonnay, S., Trancikova, A., Tsika, E., Pletnikova, O., Troncoso, J. C., Glauser, L., & Moore, D. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr606 · Cited by 161
Emerging degrader technologies engaging lysosomal pathways
Ding, Y., Xing, D., Fei, Y., & Lu, B. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00624c · Cited by 170
Song, J.-X., Lu, J.-H., Liu, L.-F., Chen, L.-L., Durairajan, S. S. K., Yue, Z., Zhang, H.-Q., & Li, M. (2014) · Autophagy · doi:10.4161/auto.26751 · Cited by 160
“As discussed in a previous study, WT and SNCA may impair autophagy in a similar way.(20) The earlier activation of autophagy by SNCA may reflect a compensatory response to its inhibition of CMA.”
BackgroundResultInfluentialOliveira, L. M. A., Falomir-Lockhart, L. J., Botelho, M. G., Lin, K.-H., Wales, P., Koch, J. C., Gerhardt, E., Taschenberger, H., Outeiro, T. F., Lingor, P., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.318 · Cited by 160
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Ghiglieri, V., Calabrese, V., & Calabresi, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00295 · Cited by 159
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
Luo, F., Sandhu, A. F., Rungratanawanich, W., Williams, G. E., Akbar, M., Zhou, S., Song, B.-J., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197174 · Cited by 158
Spermidine protects against α-synuclein neurotoxicity
Büttner, S., Broeskamp, F., Sommer, C., Markaki, M., Habernig, L., Alavian-Ghavanini, A., Carmona-Gutierrez, D., Eisenberg, T., Michael, E., Kroemer, G., et al. (2014) · Cell Cycle · doi:10.4161/15384101.2014.973309 · Cited by 158
Alessandri, C., Barbati, C., Vacirca, D., Piscopo, P., Confaloni, A., Sanchez, M., Maselli, A., Colasanti, T., Conti, F., Truglia, S., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-206060 · Cited by 156
Sundaram, S., Hughes, R. L., Peterson, E., Müller-Oehring, E. M., Brontë-Stewart, H. M., Poston, K. L., Faerman, A., Bhowmick, C., & Schulte, T. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.016 · Cited by 152
Dysfunction of Cellular Proteostasis in Parkinson’s Disease
Lehtonen, Š., Sonninen, T.-M., Wojciechowski, S., Goldsteins, G., & Koistinaho, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00457 · Cited by 147
“α-SYN is a small (14 kDa) protein that is highly expressed in neurons but can also be found in peripheral tissues and blood (Witt, 2013; Malek et al., 2014).”
BackgroundTenreiro, S., Reimão-Pinto, M. M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., Rosado-Ramos, R., Amen, T., Waiss, M., Magalhães, F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004302 · Cited by 147
Glucocerebrosidase is shaking up the synucleinopathies
Siebert, M., Sidransky, E., & Westbroek, W. (2014) · Brain · doi:10.1093/brain/awu002 · Cited by 147
“Accumulating evidence indicates that lysosomal impairment contributes to the neuropathology of Parkinson’s disease (Tofaris, 2012) and in turn, a-synuclein aggregation can impair autophagy and lysosomal function (Winslow et al., 2010).”
BackgroundRocha, E. M., Smith, G. A., Park, E., Cao, H., Graham, A.-R., Brown, E., McLean, J. R., Hayes, M. A., Beagan, J., Izen, S. C., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6307 · Cited by 145
Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein
Kilpatrick, K., Zeng, Y., Hancock, T., & Segatori, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120819 · Cited by 145
Ahmed, I., Liang, Y., Schools, S., Dawson, V. L., Dawson, T. M., & Savitt, J. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0209-12.2012 · Cited by 144
“Interestingly, aberrant A53T -synuclein is thought to be associated specifically with CMA (Cuervo et al., 2004; Winslow et al., 2010).”
BackgroundKoch, J. C., Bitow, F., Haack, J., d'Hedouville, Z., Zhang, J.-N., Tönges, L., Michel, U., Oliveira, L. M. A., Jovin, T. M., Liman, J., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.169 · Cited by 145
Targeting autophagy in neurodegenerative diseases
Vidal, R. L., Matus, S., Bargsted, L., & Hetz, C. A. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.002 · Cited by 156
Endo-lysosomal dysfunction: a converging mechanism in neurodegenerative diseases
Wang, C., Telpoukhovskaia, M. A., Bahr, B. A., Chen, X., & Gan, L. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.09.005 · Cited by 155
Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder
Khan, A. U., Akram, M., Daniyal, M., & Zainab, R. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1486837 · Cited by 142
“A variety of non-viral vectors have been introduced to present a secure strategy delivering gene, such as nanoparticles, liposomes, peptides and polymers [417].”
BackgroundAutophagy impairment in Parkinson’s disease
Karabiyik, C., Lee, M. J., & Rubinsztein, D. C. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170023 · Cited by 140
“Such strategies have potential for treating PD variants where increased levels of α-syn caused by factors like SNCA multiplication is the underlying mechanism and impairs not only autophagosome formation (46), but also endosomal trafficking (83), chaperone-mediated autophagy (84) and mitochondrial fusion (85).”
BackgroundSelf-citationZhang, Y., Wu, Q., Zhang, L., Wang, Q., Yang, Z.-X., Liu, J., & Feng, L. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104538 · Cited by 149
Autophagy and misfolded proteins in neurodegeneration
Metcalf, D. J., García-Arencibia, M., Hochfeld, W. E., & Rubinsztein, D. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.003 · Cited by 138
“We found that α-synuclein inhibits autophagosome formation in cell culture and in vivo (Winslow et al., 2010).”
BackgroundSelf-citationRole of the endolysosomal system in Parkinson’s disease
Vidyadhara, D. J., Lee, J. E., & Chandra, S. S. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14820 · Cited by 136
“A recent study on mammalian cells and transgenic mice shows that a-synuclein over-expression mediated autophagy defects are exerted through Rab1a inhibition (Winslow et al. 2010).”
BackgroundMitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
Calì, T., Ottolini, D., & Brini, M. (2011) · BioFactors · doi:10.1002/biof.159 · Cited by 134
Regulation of selective autophagy onset by a Ypt/Rab GTPase module
Lipatova, Z., Belogortseva, N., Zhang, X. Q., Kim, J., Taussig, D., & Segev, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121299109 · Cited by 131
“In addition, like the effect of the ypt1-1mutation on Atg9 localization in yeast, inhibition of Rab1a function has been shown to alter the localization of Atg9 in human cells (36).”
BackgroundParkinson's disease: convergence on synaptic homeostasis
Soukup, S., Vanhauwaert, R., & Verstreken, P. (2018) · The EMBO Journal · doi:10.15252/embj.201898960 · Cited by 130
“…these studies suggest that there is a common underlying theme where several of the genetic factors associated with PD encode proteins that affect the process of macroautophagy (Plowey et al, 2008; Winslow et al, 2010; Sánchez-Danés et al, 2012; BravoSan Pedro et al, 2013; Zavodszky et al, 2014).”
BackgroundSH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research—Old Practice for New Trends
Ioghen, O. C., Ceafalan, L. C., & Popescu, B. O. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201020 · Cited by 160
α-Synuclein and Neuronal Cell Death
Yasuda, T., Nakata, Y., & Mochizuki, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8327-0 · Cited by 129
Secretory versus degradative autophagy: unconventional secretion of inflammatory mediators
Jiang, S., Dupont, N., Castillo, E. F., & Deretic, V. (2013) · Journal of Innate Immunity · doi:10.1159/000346707 · Cited by 129
Defective Autophagy in Parkinson’s Disease: Role of Oxidative Stress
Janda, E., Isidoro, C., Carresi, C., & Mollace, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8318-1 · Cited by 140
Protein misfolding disorders and macroautophagy
Menzies, F. M., Moreau, K., & Rubinsztein, D. C. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.10.010 · Cited by 129
Self-citationConsensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar Ataxias
Matilla‐Dueñas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K. N., Pandolfo, M., Pulst, S. M., Rieß, O., Rubinsztein, D. C., Schmidt, J., et al. (2013) · The Cerebellum · doi:10.1007/s12311-013-0539-y · Cited by 145
Self-citationAutophagy deregulation in neurodegenerative diseases – recent advances and future perspectives
Cheung, Z. H., & Ip, N. Y. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07314.x · Cited by 127
“Over-expression of wild-type a-synuclein is associated with autophagy inhibition (Winslow et al. 2010).”
BackgroundLoss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice
Sato, S., Uchihara, T., Fukuda, T., Noda, S., Kondo, H., Saiki, S., Komatsu, M., Uchiyama, Y., Tanaka, K., & Hattori, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-21325-w · Cited by 125
Chua, C. E. L., Gan, B. Q., & Tang, B. L. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0748-9 · Cited by 146
The Parkinson disease protein α-synuclein inhibits autophagy
Winslow, A. R., & Rubinsztein, D. C. (2011) · Autophagy · doi:10.4161/auto.7.4.14393 · Cited by 126
Self-citationMitochondrial Dysfunction in Neural Injury
Zhao, X., Lu, M., Yuan, D., Xu, D.-E., Yao, P.-P., Ji, W., Chen, H., Liu, W., Yan, C.-X., Xia, Y., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00030 · Cited by 136
“…compromised autophagy activity, which was evidenced by increased levels of p62, decreased levels of LC3 and the number of LC3-II-positive vesicles (Winslow et al., 2010). α-Syn overexpression also leads to the mislocalization of autophagy related protein 9 (ATG9) via inhibiting Rab1 GTPase…”
BackgroundLysosomal adaptation: how the lysosome responds to external cues
Settembre, C., & Ballabio, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016907 · Cited by 126
“A very common feature of LSDs is early-onset neurodegeneration with severe and often fatal consequences (Jeyakumar et al. 2005).”
BackgroundInfluentialDual Role of Autophagy in Diseases of the Central Nervous System
Bar-Yosef, T., Damri, O., & Agam, G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00196 · Cited by 125
“Inhibition of autophagy by α-synuclein over-expression has been shown to result in mislocalization of the autophagy protein Atg9 and to decrease autophagosome precursors formation (Winslow et al., 2010).”
BackgroundSNCA (α-synuclein)-induced toxicity in yeast cells is dependent on Sir2-mediated mitophagy
Sampaio-Marques, B., Felgueiras, C., Silva, A., Rodrigues, M., Tenreiro, S., Franssens, V., Reichert, A. S., Outeiro, T. F., Winderickx, J., & Ludovico, P. (2012) · Autophagy · doi:10.4161/auto.21275 · Cited by 123
A metabolic profile of polyamines in parkinson disease: A promising biomarker
Saiki, S., Sasazawa, Y., Fujimaki, M., Kamagata, K., Kaga, N., Taka, H., Li, Y., Souma, S., Hatano, T., Imamichi, Y., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25516 · Cited by 122
Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
Wong, Y. C., Luk, K., Purtell, K., Burke Nanni, S., Stoessl, A. J., Trudeau, L., Yue, Z., Krainc, D., Oertel, W., Obeso, J. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27823 · Cited by 122
Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
Li, D., & Liu, C. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00603-7 · Cited by 125
Autophagosome dynamics in neurodegeneration at a glance
Wong, Y. C., & Holzbaur, E. L. F. (2015) · Journal of Cell Science · doi:10.1242/jcs.161216 · Cited by 119
“inhibits autophagy by inhibition of Rab1a, leading to Atg9 mislocalization and defective omegasome and autophagosome formation (Winslow et al., 2010).”
BackgroundSoo, K. Y., Halloran, M. A., Sundaramoorthy, V., Parakh, S., Toth, R. P., Southam, K. A., McLean, C., Lock, P., King, A. E., Farg, M. A., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1468-2 · Cited by 135
Lysosome‐dependent pathways as a unifying theme in Parkinson's disease
Tofaris, G. K. (2012) · Movement Disorders · doi:10.1002/mds.25136 · Cited by 118
“Accordingly, in cell or animal models, overexpression of a-Syn has been shown to impair mitochondrial membrane fusion,(66) reduce the synaptic vesicular recycling pool,(29) and inhibit endosomal-trafficking(67) chaperone-mediated autophagy(68) and macroautophagy.(69) The relevance of this model in sporadic PD is suppo…”
BackgroundER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway
Mercado, G., Castillo, V., Soto, P., & Sidhu, A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.042 · Cited by 135
“In pathological conditions, αSyn can impair all these degradation pathways, and furthermore, disturbances in the autophagy-lysosomal system can contribute to its toxicity and accumulation in the cell, triggering ER stress (Chu et al., 2009; Decressac and Bjorklund, 2013; Winslow et al., 2010).”
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F., & Florio, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040901 · Cited by 118
Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations
Ahmed, H., Abushouk, A. I., Gabr, M., Negida, A., & Abdel‐Daim, M. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.100 · Cited by 138
RAB2 regulates the formation of autophagosome and autolysosome in mammalian cells
Ding, X., Jiang, X., Tian, R., Zhao, P., Li, L., Wang, X., Chen, S., Zhu, Y., Mei, M., Bao, S., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596478 · Cited by 118
Kong, Y., Liang, X., Liu, L., Zhang, D., Wan, C., Gan, Z., & Yuan, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137432 · Cited by 117
The puzzling origin of the autophagosomal membrane
Mari, M., Tooze, S. A., & Reggiori, F. (2011) · F1000 Biology Reports · doi:10.3410/b3-25 · Cited by 117
The Interplay between Ca2+ Signaling Pathways and Neurodegeneration
Ureshino, R. P., Erustes, A. G., Bassani, T. B., Wachilewski, P., Guarache, G. C., Nascimento, A. C., Costa, A. J., Smaili, S. S., & da Silva Pereira, G. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236004 · Cited by 117
Ganesan, D., & Cai, Q. (2021) · Biochemical Journal · doi:10.1042/bcj20200917 · Cited by 131
Cytoplasmic dynein in neurodegeneration
Eschbach, J., & Dupuis, L. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.004 · Cited by 134
Ryter, S. W., Bhatia, D., & Choi, M. E. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7518 · Cited by 114
Autophagy in inflammation, infection, neurodegeneration and cancer
Arroyo, D. S., Gaviglio, E. A., Peralta Ramos, J. M., Bussi, C., Rodriguez-Galan, M. C., & Iribarren, P. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.001 · Cited by 115
Gao, J., Perera, G., Bhadbhade, M., Halliday, G. M., & Dzamko, N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008733 · Cited by 113
The Vicious Cycle Between α ‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
Bellomo, G., Paciotti, S., Gatticchi, L., & Parnetti, L. (2019) · Movement Disorders · doi:10.1002/mds.27895 · Cited by 127
“In mammalian cells and in transgenic mice, overexpression of WT and both A30P and A53T mutated α-syn leads to inhibition of macroautophagy,(120,121) which is caused by a reduction in autophagosome formation through α-syn/Rab1a interaction.(120) Furthermore, in α-syn transgenic mice, intracerebral infusion of rapamycin…”
BackgroundKoprich, J. B., Johnston, T. H., Huot, P., Reyes, M. G., Espinosa, M., & Brotchie, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017698 · Cited by 111
Circadian clocks and neurodegenerative diseases: time to aggregate?
Hastings, M. H., & Goedert, M. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.004 · Cited by 112
The role of membrane-trafficking small GTPases in the regulation of autophagy
Bento, C. F., Puri, C., Moreau, K., & Rubinsztein, D. C. (2013) · Journal of Cell Science · doi:10.1242/jcs.123075 · Cited by 111
Self-citationThe Interplay between Alpha-Synuclein Clearance and Spreading
Lopes da Fonseca, T., Villar-Piqué, A., & Outeiro, T. (2015) · Biomolecules · doi:10.3390/biom5020435 · Cited by 109
Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation
Martínez‐Vicente, M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.03.005 · Cited by 123
Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 119
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Lee, J., Sung, K. W., Bae, E.-J., Yoon, D., Kim, D., Lee, J. S., Park, D.-H., Park, D. Y., Mun, S. R., Kwon, S. C., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00630-7 · Cited by 123
“Given the evidence that the α-syn overexpression cellular model showed decreased Rab1a activity with subsequent reduction in the activity of Atg9, causing decreased DFCP1+ and LC3+ punctate levels [46], we speculated that high molecular weight toxic α-syn species are likely to be involved in the suppression of autopha…”
BackgroundResultPoststroke Induction of -Synuclein Mediates Ischemic Brain Damage
Kim, T., Mehta, S. L., Kaimal, B., Lyons, K., Dempsey, R. J., & Vemuganti, R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1241-16.2016 · Cited by 106
“In addition, overexpression of wild-type -Syn resulted in impaired macroautophagy via Rab1a inhibition (Winslow et al., 2010).”
BackgroundSteneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Östenson, C.-G., & Edlund, H. (2013) · Diabetes · doi:10.2337/db12-1045 · Cited by 106
“2 at insulin granules (31) and overexpression of a-synuclein in vitro, possibly by negatively affecting Rab1a function, impairs growth hormone secretion and autophagy in mammalian cells (32), providing additional, microtubuleindependent, mechanistic implications of increased levels of a-synuclein (Fig.”
BackgroundCan Parkinson's disease pathology be propagated from one neuron to another?
Dunning, C. J. R., Reyes, J. F., Steiner, J. A., & Brundin, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.11.003 · Cited by 124
“αSyn can directly impair autophagy by inhibiting Rab1 (Winslow et al., 2010).”
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Biasiotto, G., Lorenzo, D. D., Archetti, S., & Zanella, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9473-y · Cited by 109
Autophagy in Neurodegenerative Diseases and Metal Neurotoxicity
Zhang, Z., Miah, M. R., Culbreth, M. E., & Aschner, M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1844-x · Cited by 107
Abushouk, A. I., Negida, A., Ahmed, H., & Abdel‐Daim, M. M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.074 · Cited by 120
Ren, H., Zhai, W., Lu, X., & Wang, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.691881 · Cited by 114
Bussi, C., Peralta Ramos, J. M., Arroyo, D. S., Gaviglio, E. A., Gallea, J. I., Wang, J. M., Celej, M. S., & Iribarren, P. (2017) · Scientific Reports · doi:10.1038/srep43153 · Cited by 103
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
Tyson, T., Steiner, J. A., & Brundin, P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13449 · Cited by 102
Chen, Y., Lian, Y., Ma, Y., Wu, C., Zheng, Y., & Xie, N. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.12.001 · Cited by 107
“Increased expression of a-synuclein is a key factor in the pathogenic process of PD (Winslow et al., 2010; Rocha et al., 2017).”
BackgroundTherapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
Jasutkar, H. G., Oh, S. E., & Mouradian, M. M. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000133 · Cited by 111
“Reducing a -Syn phosphorylation pharmacologically through activating PP2A is particularly pertinent mechanistically considering that in PD and DLB brains, PP2A is demethylated, PME1 is upregulated, and the methylating enzyme leucine carboxyl methyltransferase is downregulated (Park et al., 2016).”
BackgroundMitochondrial Quality Control and Dynamics in Parkinson's Disease
McCoy, M. K., & Cookson, M. R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4019 · Cited by 101
Autophagy in neuronal cells: general principles and physiological and pathological functions
Daμμe, M., Suntio, T., Säftig, P., & Eskelinen, E. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1361-4 · Cited by 119
Autophagy in Parkinson’s Disease
Nechushtai, L., Frenkel, D., & Pinkas‐Kramarski, R. (2023) · Biomolecules · doi:10.3390/biom13101435 · Cited by 115
“In addition, elevated levels of intracellular α -Syn due to inhibition of the GTPase Rab1A have been shown to hamper omegasome formation by affecting Atg9 localization [116].”
BackgroundKett, L. R., Stiller, B., Bernath, M. M., Tasset, I., Blesa, J., Jackson-Lewis, V., Chan, R. B., Zhou, B., Di Paolo, G., Przedborski, S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0632-14.2015 · Cited by 100
“…of -synuclein by both macroautophagy and CMA (Webb et al., 2003; Cuervo et al., 2004; Martinez-Vicente et al., 2008; Vogiatzi et al., 2008; Winslow et al., 2010; Ebrahimi-Fakhari et al., 2011; Xilouri et al., 2013) and of the disruption of this process in other PD models, we next analyzed…”
BackgroundMitophagy in neurodegenerative diseases
Rodolfo, C., Campello, S., & Cecconi, F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.004 · Cited by 100
“…by reduced levels of Beclin 1 mRNA and protein, as observed in AD (Pickford et al., 2008); mutations in the a-synuclein (SNCA) (Tanik et al., 2013; Winslow et al., 2010) and LRKK2 (Schapansky et al., 2014), as detected in PD; formation of mutated huntingtin (mHtt)/Beclin 1 (Shibata et al., 2006),…”
BackgroundVollrath, J. T., Sechi, A., Dreser, A., Katona, I., Wiemuth, D., Vervoorts, J., Dohmen, M., Chandrasekar, A., Prause, J., Brauers, E., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.243 · Cited by 99
p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 99
Nitrosative stress in Parkinson’s disease
Stykel, M. G., & Ryan, S. D. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00370-3 · Cited by 94
Autophagic pathways in Parkinson disease and related disorders
Xilouri, M., & Stefanis, L. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001803 · Cited by 113
Key genes and convergent pathogenic mechanisms in Parkinson disease
Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 127
“Finally, it has been proposed that RAB protein sequestration mediated by α-synuclein blocks autophagosome formation 228 . α-Synuclein fibrils cannot be degraded by macroautophagy and have been observed to block the maturation of autophagosomes upstream of their fusion with lysosomes 229 .”
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion
Tang, Q., Gao, P., Arzberger, T., Höllerhage, M., Herms, J., Höglinger, G., & Koeglsperger, T. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04138-0 · Cited by 103
Helley, M., Pinnell, J. R., Sportelli, C., & Tieu, K. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00177 · Cited by 110
“Overexpression of wild type α-synuclein was shown to directly modulate autophagy via inhibition of Rab1a protein, which is important for autophagosome formation (Winslow et al., 2010).”
BackgroundTherapeutic implication of autophagy in neurodegenerative diseases
Rahman, M. A., & Rhim, H. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.7.069 · Cited by 106
Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Trancikova, A. K., Tsika, E., & Moore, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4200 · Cited by 100
Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
Budini, M., Buratti, E., Morselli, E., & Criollo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00170 · Cited by 106
“This reduces the clearance of the protein αsynuclein, which accumulates in intra-neuronal inclusions called Lewy bodies, a feature of the brain tissue of PD patients (Winslow et al., 2010).”
BackgroundAutophagy, Cellular Aging and Age-related Human Diseases
Cheon, S. Y., Kim, H. J., Rubinsztein, D. C., & Lee, J. E. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.643 · Cited by 104
“Overexpression of α-synuclein, which is seen in forms of PD, impairs macroautophagy and increases p62 levels due to ATG9 mislocation [145].”
BackgroundSelf-citationMinireview: Autophagy in Pancreatic β-Cells and Its Implication in Diabetes
Watada, H., & Fujitani, Y. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1367 · Cited by 99
Perera, N. D., Sheean, R. K., Lau, C. L., Shin, Y. S., Beart, P. M., Horne, M. K., & Turner, B. J. (2018) · Autophagy · doi:10.1080/15548627.2017.1385674 · Cited by 89
Selective vulnerability in α-synucleinopathies
Alegre-Abarrategui, J., Brimblecombe, K. R., Roberts, R. F., Velentza-Almpani, E., Tilley, B. S., Bengoa-Vergniory, N., & Proukakis, C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02010-2 · Cited by 87
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.